Table 2.
Summary of polymeric carrier Mater for LNs immunotherapy
| Polymeric carrier material | Loading drug | Type of cancer | References |
|---|---|---|---|
| PPS | CpG | EL4 tumor model | [165] |
| PLGA | TLR 7/8 agonists | B16F10-OVA tumor model, MB49 tumor model and Renca-GL tumor model | [166] |
| PLGA | Imiquimod | B16-OVA tumor model, B16F10-Luc tumor model and CT26 tumor model | [107] |
| PEG-PE | MPLA and OVA/E7 | TC-1 tumor model | [164] |
| PEG-b-PAsp | TRP2 peptide | B16F10 tumor model | [108] |
| PLA-PEI | CpG and OVA | B16-OVA tumor model, MC38 tumor model and E0771 tumor model | [158] |
| DSPE-PEG2000 | IR-780 | 4T1 tumor model | [167] |
| DSPE-PEG | PTX | 4T1 tumor model and 4T1-luc tumor model | [106] |
| Ct | OVA | B16F10-OVA tumor model | [168] |
| MPDA | R837 | B16-OVA tumor model | [159] |